ArticleCureus2025
Systemic Lupus Erythematosus Presenting Primarily With End-Stage Renal Disease in Men: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report describes a diagnostically challenging presentation of systemic lupus erythematosus (SLE) in a 37-year-old male patient with a five-year history of isolated chronic kidney disease (CKD) requiring hemodialysis, who acutely developed progressive multi-organ failure. Initial evaluation revealed severe pancytopenia, hypoalbuminemia, elevated cardiac biomarkers, and multi-cavity effusions. Autoimmune serology confirmed the diagnosis of SLE with characteristic autoantibodies. Critical complications included refractory septic shock, extensive coronary artery disease, splenic infarction, cerebral hemorrhage, and terminal multi-organ failure. Despite multidisciplinary intervention, rapid clinical deterioration resulted in a fatal outcome. This case highlights that isolated CKD can obscure SLE onset in men, emphasizing the need for early serological screening in unexplained multisystem deterioration, even in the absence of classic lupus features, to prevent diagnostic delays and fatal complications. To our knowledge, this is the first report of SLE in a male patient presenting as isolated CKD for five years before fatal multi-organ failure, highlighting gender-specific diagnostic challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.